DeuterOncology (SA)

Active

VAT

BE 0754.971.388

Address

Clos Chanmurly 13

4000 Liège

Established

28-09-2020

Principal activity

Manufacture of basic pharmaceutical products

Try for free

Crisis resilience of DeuterOncology

Which companies are best armed against current economic trends and the energy crisis?

2023		2022		2021
Profit/Loss	-€2,029,591	15%	-€2,387,844	-117%	-€1,100,339
Equity	€1,707,402	-48%	€3,309,968	> 1.000%	-€35,343
Gross margin	-€1,864,132	19%	-€2,294,417	-108%	-€1,102,510

Publications in the Belgian Official Journal for DeuterOncology

Type	Date	Pdf	Subject
	20-06-2024		Capital, Shares (FR)
	26-09-2023		Resignations, Appointments (FR)
	28-06-2023		Articles of Association (Translation, Coordination, Other Modifications, …) - Capital, Shares (FR)
	02-01-2023		Articles of Association (Translation, Coordination, Other Modifications, …) - Capital, Shares - Resi… (FR)
	09-08-2022		Articles of Association (Translation, Coordination, Other Modifications, …) - Miscellaneous (FR)

Sources

Frequently asked questions

What is the VAT number of DeuterOncology?

The VAT number of DeuterOncology is BE0754971388.

When was DeuterOncology founded?

DeuterOncology was founded on 28-09-2020.

What is the address of DeuterOncology?

The current registered office of DeuterOncology is located at Clos Chanmurly 13, 4000 Liège.

When was the last time DeuterOncology filed their annual financial statements?

The most recent financial statements of DeuterOncology were filed on 27-06-2024. You can view them here.

How many employees does DeuterOncology have?

There are currently no employees working at DeuterOncology or no workforce information is available.

What is the annual turnover of DeuterOncology?

At the time of its most recent financial statements, DeuterOncology did not publish any turnover figures. DeuterOncology reported a gross margin of -€1,864,132.50.